Stimulating Erythropoiesis: Future Perspectives

Publisher： Karger

E-ISSN： 1423-0143|31|4|234-246

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.31, Iss.4, 2008-06, pp. : 234-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-02 ,pp. : 235-247

Karger

Access to resources Recommend Favorite

Implications of a Reduction in the Hemoglobin Target in Erythropoiesis-Stimulating Agent-Treated Hemodialysis Patients

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen

By  

Nephron Extra, Vol. 1, Iss. 1, 2011-08 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors

By  

Blood Purification, Vol. 29, Iss. 2, 2010-01 ,pp. : 86-92

Karger

Access to resources Recommend Favorite

Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients

By  

Nephron, Vol. 131, Iss. 2, 2015-0 ,pp. : 123-130

Karger

Access to resources Recommend Favorite